Early-Life Exposure to Air and Light Pollution Linked to Increased Risk of Pediatric Thyroid Cancer Apr. 18, 2025 — A new study suggests that early-life exposure to two widespread environmental ...

Previous estimates had put this risk closer to ... Master Regulator Blocking Immunotherapy, Paving the Way for a New Lung Cancer Treatment Apr. 9, 2025 — Researchers have discovered that 'DEAD ...

Someone understands your core needs, creating a fine balance and giving you all the support you need to blossom. Dont allow any toxic contacts into your world ... Cancer - traits, personality, dates, ...

Friends and more friends, you can never have enough of them, eh, Cancer? Today's Last Quarter Moon invites you to get to know people better. Expanding your social network to have a referral ...

Long-term dreams may be at odds with urgent needs. How do you save for your aspirations with money going elsewhere? The sun conflicting with Mars flares material tensions. Know that this is just a ...

An international research team led by a Boston College professor has uncovered a drug and diet pairing that could fight a deadly brain cancer The international team combined a calorie-restricted diet ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk glands or ducts of the breast (ductal epithelium). Breast ...

You must make space for the relationship you want, dearest Cancer. You have been alone for a while, even if you’re newly single or still struggling to end a relationship. Being on your own ...

The treatment of poorly differentiated thyroid cancer and anaplastic thyroid cancer remains challenging. Here, the authors perform multi-omic analysis of thyroid samples and identify proteomic ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

AbbVie's Elahere has been shown to reduce the risk of death in patients with folate receptor-alpha (FRα) positive, platinum-resistant ovarian cancer by a third, reinforcing its blockbuster ...